HIV Drugs and Alzheimer's; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes

(MedPage Today) — Nucleoside reverse transcriptase inhibitors — antiretroviral drugs approved to treat HIV and hepatitis B — were associated with a lower incidence of Alzheimer’s disease in two large insurance databases. (Alzheimer’s &amp…

Source link : https://www.medpagetoday.com/neurology/generalneurology/115568

Author :

Publish date : 2025-05-13 18:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

HIV Drugs and Alzheimer’s; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes

Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress

Doctors, Other Healthcare Workers Strike in Washington State

Related Posts

Proton Pump Inhibitors and Hypertension; AI Fetal Cardiac Scans; ‘Work Diet’

Fixable Factors Help Drive Disparities in Access to COVID Treatment

A Neanderthal-shaped skull may explain why some people get headaches

Synthetic Nicotine Storms Onto the Vaping Scene

How to Have ‘The Talk’ — About Vaccines

Shrinking Antarctic sea ice is warming the ocean faster than expected

Proton Pump Inhibitors and Hypertension; AI Fetal Cardiac Scans; ‘Work Diet’

Fixable Factors Help Drive Disparities in Access to COVID Treatment

A Neanderthal-shaped skull may explain why some people get headaches

Synthetic Nicotine Storms Onto the Vaping Scene

How to Have ‘The Talk’ — About Vaccines

Shrinking Antarctic sea ice is warming the ocean faster than expected

‘Notable’ rise in dads over 60 in England and Wales

Earwax Secretions May Help Detect Parkinson’s Disease

Categories

Archives